| pubmed-article:12114336 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12114336 | lifeskim:mentions | umls-concept:C0080103 | lld:lifeskim |
| pubmed-article:12114336 | lifeskim:mentions | umls-concept:C0442043 | lld:lifeskim |
| pubmed-article:12114336 | lifeskim:mentions | umls-concept:C0040034 | lld:lifeskim |
| pubmed-article:12114336 | lifeskim:mentions | umls-concept:C0019134 | lld:lifeskim |
| pubmed-article:12114336 | lifeskim:mentions | umls-concept:C0272285 | lld:lifeskim |
| pubmed-article:12114336 | lifeskim:mentions | umls-concept:C0205265 | lld:lifeskim |
| pubmed-article:12114336 | lifeskim:mentions | umls-concept:C0449774 | lld:lifeskim |
| pubmed-article:12114336 | lifeskim:mentions | umls-concept:C1555582 | lld:lifeskim |
| pubmed-article:12114336 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:12114336 | pubmed:dateCreated | 2002-7-12 | lld:pubmed |
| pubmed-article:12114336 | pubmed:abstractText | Heparin-induced thrombocytopenia (HIT) is an immune-mediated adverse drug reaction associated with a decrease of platelet counts that usually begins after at least 5 days of heparin treatment. Uncertainty exists about the risk of early onset of HIT (ie, < 5 days) in relation to previous heparin exposure. We therefore analyzed the temporal pattern of thrombocytopenia in patients with laboratory-confirmed HIT to assess whether patients with previous heparin exposure have an increased risk of early onset of HIT. | lld:pubmed |
| pubmed-article:12114336 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12114336 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12114336 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12114336 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:12114336 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12114336 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12114336 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12114336 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:12114336 | pubmed:issn | 0012-3692 | lld:pubmed |
| pubmed-article:12114336 | pubmed:author | pubmed-author:EichlerPetraP | lld:pubmed |
| pubmed-article:12114336 | pubmed:author | pubmed-author:LubenowNorber... | lld:pubmed |
| pubmed-article:12114336 | pubmed:author | pubmed-author:GreinacherAnd... | lld:pubmed |
| pubmed-article:12114336 | pubmed:author | pubmed-author:KempfReinerR | lld:pubmed |
| pubmed-article:12114336 | pubmed:author | pubmed-author:EichnerAngeli... | lld:pubmed |
| pubmed-article:12114336 | pubmed:author | pubmed-author:CarlssonLena... | lld:pubmed |
| pubmed-article:12114336 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12114336 | pubmed:volume | 122 | lld:pubmed |
| pubmed-article:12114336 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12114336 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12114336 | pubmed:pagination | 37-42 | lld:pubmed |
| pubmed-article:12114336 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12114336 | pubmed:meshHeading | pubmed-meshheading:12114336... | lld:pubmed |
| pubmed-article:12114336 | pubmed:meshHeading | pubmed-meshheading:12114336... | lld:pubmed |
| pubmed-article:12114336 | pubmed:meshHeading | pubmed-meshheading:12114336... | lld:pubmed |
| pubmed-article:12114336 | pubmed:meshHeading | pubmed-meshheading:12114336... | lld:pubmed |
| pubmed-article:12114336 | pubmed:meshHeading | pubmed-meshheading:12114336... | lld:pubmed |
| pubmed-article:12114336 | pubmed:meshHeading | pubmed-meshheading:12114336... | lld:pubmed |
| pubmed-article:12114336 | pubmed:meshHeading | pubmed-meshheading:12114336... | lld:pubmed |
| pubmed-article:12114336 | pubmed:meshHeading | pubmed-meshheading:12114336... | lld:pubmed |
| pubmed-article:12114336 | pubmed:meshHeading | pubmed-meshheading:12114336... | lld:pubmed |
| pubmed-article:12114336 | pubmed:meshHeading | pubmed-meshheading:12114336... | lld:pubmed |
| pubmed-article:12114336 | pubmed:meshHeading | pubmed-meshheading:12114336... | lld:pubmed |
| pubmed-article:12114336 | pubmed:meshHeading | pubmed-meshheading:12114336... | lld:pubmed |
| pubmed-article:12114336 | pubmed:meshHeading | pubmed-meshheading:12114336... | lld:pubmed |
| pubmed-article:12114336 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12114336 | pubmed:articleTitle | Heparin-induced thrombocytopenia: temporal pattern of thrombocytopenia in relation to initial use or reexposure to heparin. | lld:pubmed |
| pubmed-article:12114336 | pubmed:affiliation | Department of Immunology and Transfusion Medicine, Ernst-Moritz-Arndt University, Greifswald, Germany. | lld:pubmed |
| pubmed-article:12114336 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12114336 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12114336 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12114336 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12114336 | lld:pubmed |
